E014 Patient experience of switching to biosimilar Benepali-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

E014 Patient experience of switching to biosimilar Benepali

Published:2019-04-01 Issue:Supplement_3 Volume:58 Page:
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Ahmad Nadia¹,Morsley Klara¹,Allard Andrew¹,Yein Khin¹,Hall Katie¹,Watson Elizabeth¹,Price Elizabeth¹,Collins David¹,Ahmed Azeem¹,Carty Sara¹,Waller Rosemary¹

Affiliation:

1. Rheumatology, Great Western Hospital, Swindon, UNITED KINGDOM

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/58/Supplement_3/kez110.013/28711758/kez110.013.pdf

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rheumatology Patients’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar;ACR Open Rheumatology;2023-11-23

2. The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review;Advances in Therapy;2021-11-15

3. The mode of delivery and content of communication strategies used in mandatory and non-mandatory biosimilar transitions: a systematic review with meta-analysis;Health Psychology Review;2021-08-30

4. Etanercept;Reactions Weekly;2019-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP